SENISCA appoints Tim Edwards as Chair of the Board
10 Sep 2024 //
GLOBENEWSWIRE
SENISCA secures additional £3.7 to support the senotherapeutic platform
18 Mar 2024 //
GLOBENEWSWIRE
SENISCA appoints Dr. Sarah Cole as Chief Executive Officer
02 Nov 2023 //
GLOBENEWSWIRE
SENISCA shortlisted for 2022/2023 Nature Spinoff prize
25 May 2023 //
GLOBENEWSWIRE
SENISCA awarded Innovate UK grant to develop oligonucleotide therapeutics
20 Apr 2023 //
GLOBENEWSWIRE